Debashis Sarker

机构：Guy's Hospital, King's College - North Carolina, King's College London, Guy's and St Thomas' NHS Foundation Trust, King's College Hospital, U-M Rogel Cancer Center · ORCID：0000-0003-4814-8429

发表论文 345 篇 · 总被引 8330 次 · h-index 36

代表论文

• Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma (2025 · Journal of Hepatology · 被引 11)
• 1515MO Clinical outcomes and PD-L1 expression analyses from a trial of mRNA-4359 plus pembrolizumab in checkpoint inhibitor-resistant/refractory (CPI-R/R) melanoma (2025 · Annals of Oncology · 被引 3)
• Prognosis of NETs has there been improvement over the last 30 years (2025 · Neuroendocrinology · 被引 2)
• Fianlimab, a human lymphocyte activation gene‐3 monoclonal antibody, in combination with cemiplimab: Tumor‐specific expansion cohorts in advanced malignancies (2026 · Cancer · 被引 1)
• Dendrimer-Nanoparticle (DEP) Delivery of Topoisomerase I Inhibitor, SN38 (DEP-SN38): Safety, Tolerability, and Preliminary Efficacy Study in Patients With Advanced Solid Tumors (2025 · Journal of Clinical Oncology · 被引 1)
• Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework (2026 · British Journal of Cancer)